Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients

Annals of Surgical Oncology

Volumn 6, Issue 5, 1999, Pages 450-454

  Linehan, David C ^a   Hill, Arnold D K ^a   Akhurst, Timothy ^a   Yeung, Henry ^a   Yeh, Samuel D J ^a   Tran, Katherine N ^a   Borgen, Patrick I ^a   Cody III, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer surgery; Sentinel node biopsy

Indexed keywords

DYE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARENCHYMA;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST NEOPLASMS; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0032776545     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0450-4     Document Type: Article

References (26)

1. Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg 1995;32:259-323.
2. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
4. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
5. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
6. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
7. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
8. Pijpers R, Hoekstra OS, Collet GJ, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
9. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997;23:495-502.
10. Galimberti V, Zurrida S, Zucali P, Luini A. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 1998;7:8-10.
11. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
12. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Breast Journal 1998;4:67-74.
13. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran. Cancer 1998;82:1704-8.
14. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339: 941-6.
15. Crossin JA, Johnson AC, Stewart PB, Turner WW. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998;64:666-9.
16. Snider H, Dowlatshahi K, Fan M, Bridger WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998;176:305-10.
17. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
18. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
19. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
20. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998;85:991-3.
21. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;349:1668-9.
22. O'Hea BJ, Hill ADK, El-Shirbiny A, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
23. Barnwell JM, Arredondo MA, Kollmorgen D, et. al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-30.
24. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229: 528-35.
25. Linehan DC, Hill ADK, Tran KN, et al. Sentinel lymph node localization in breast cancer: unfiltered isotope is superior to filtered. J Am Coll Surg 1999;188:377-81.
26. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.